Tasks such as completing the plaintiff fact sheets and reviewing medical records can quickly become overwhelming, especially when court deadlines are fast approaching.read more
When accepting a mass tort case, it can be a daunting task to manage a large group of clients. Whether a firm is brand new to mass tort litigation or just looking to brush up on best practices, below are tips to improve the flow of information – both to clients and to the firm.read more
Opioid litigation is a hot topic in the U.S. legal community. In response to the country’s opioid crisis, several states, individuals, and other local governments have filed lawsuits against various prescription opioid manufacturers and distributors.
After years of limited guidance, the Supreme Court has finally provided direction to lower courts on the issue of preemption when they delivered their opinion in Merck v. Albrecht. “Preemption” is a common defense used by defendants in pharmaceutical mass tort litigation. Through this defense, pharmaceutical companies argue that the state law causes of action are preempted by the Food and Drug Administration’s (FDA) control over drug and medical device approval and labeling.